Tu1704 EFFICACY OF ETRASIMOD AT WEEK 52 AMONG SUBJECTS WHO REACHED CLINICAL RESPONSE AT WEEK 12: POST HOC ANALYSIS OF THE PHASE 3 ELEVATE UC 52 TRIAL | Publicación